|
MFHAS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.231130E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.576900E-04 |
| Normal-vs-Stage2 |
1.473750E-02 |
| Normal-vs-Stage3 |
7.964600E-03 |
| Normal-vs-Stage4 |
8.562300E-03 |
| Stage1-vs-Stage2 |
9.606800E-01 |
| Stage1-vs-Stage3 |
7.902400E-01 |
| Stage1-vs-Stage4 |
6.279200E-01 |
| Stage2-vs-Stage3 |
8.603600E-01 |
| Stage2-vs-Stage4 |
6.419600E-01 |
| Stage3-vs-Stage4 |
7.436600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.362860E-04 |
| Normal-vs-AfricanAmerican |
2.663700E-03 |
| Normal-vs-Asian |
9.72509994756621E-09 |
| Caucasian-vs-AfricanAmerican |
8.245800E-01 |
| Caucasian-vs-Asian |
1.589270E-04 |
| AfricanAmerican-vs-Asian |
4.751800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.83239999995699E-06 |
| Normal-vs-Female |
4.015400E-01 |
| Male-vs-Female |
3.295900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.064900E-03 |
| Normal-vs-Extreme_Weight |
5.77499999999675E-05 |
| Normal-vs-Obese |
5.378300E-02 |
| Normal-vs-Extreme_Obese |
4.21950000000226E-05 |
| Normal_Weight-vs-Extreme_Weight |
5.919600E-01 |
| Normal_Weight-vs-Obese |
2.788600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.855600E-02 |
| Extreme_Weight-vs-Obese |
5.912200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.189700E-02 |
| Obese-vs-Extreme_Obese |
1.675830E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.467800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.536500E-03 |
| Normal-vs-Age(61-80Yrs) |
4.79840000000564E-06 |
| Normal-vs-Age(81-100Yrs) |
4.23760000423101E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.716200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.167000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.360400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.397600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.360100E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.176130E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.25069999999694E-05 |
| Normal-VS-Type2 PRCC |
4.824900E-04 |
| Normal-VS-KIRP CIMP |
3.466200E-01 |
| Normal-VS-Unclassified PRCC |
5.442600E-04 |
| Type1 PRCC-VS-Type2 PRCC |
8.497600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.094300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.894600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.822500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.676000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.723700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.93690000494362E-08 |
| Normal-vs-N1 |
1.483400E-01 |
| Normal-vs-N2 |
7.729600E-01 |
| N0-vs-N1 |
1.027970E-01 |
| N0-vs-N2 |
2.646800E-01 |
| N1-vs-N2 |
3.389600E-01 |
|
|
